These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Partial thyroid arterial embolization for the treatment of hyperthyroidism. Brzozowski K; Piasecki P; Zięcina P; Frankowska E; Jaroszuk A; Kamiński G; Bogusławska-Walecka R Eur J Radiol; 2012 Jun; 81(6):1192-6. PubMed ID: 21501939 [TBL] [Abstract][Full Text] [Related]
8. [A study of biological and histological criteria of thyroid autoimmunity in diffuse goiters with hyperthyroidism]. Leprat F; Felicie-Dellan E; Trouette H; Latapie MJ; Masson B; De Mascarel A; Latapie JL; Roger P Ann Endocrinol (Paris); 1997; 58(5):393-8. PubMed ID: 9685997 [TBL] [Abstract][Full Text] [Related]
9. Assays of TSH-receptor antibodies in 576 patients with various thyroid disorders: their incidence, significance and clinical usefulness. Macchia E; Concetti R; Borgoni F; Cetani F; Fenzi GF; Pinchera A Autoimmunity; 1989; 3(2):103-12. PubMed ID: 2577491 [TBL] [Abstract][Full Text] [Related]
11. Long-term immunological study in Graves' disease treated with thyroid arterial embolization. Zhao W; Gao BL; Jin CZ; Yi GF; Yang HY; Li H; Song DP; Hu JH; Jiang YN J Clin Immunol; 2008 Sep; 28(5):456-63. PubMed ID: 18633697 [TBL] [Abstract][Full Text] [Related]
12. Simultaneous assay for three types of thyrotropin receptor antibody activities using FRTL-5 cells in patients with autoimmune thyroid diseases. Zhu Y; Portmann L; Dénéréaz N; Lemarchand-Béraud T Eur J Endocrinol; 1994 Oct; 131(4):359-68. PubMed ID: 7921224 [TBL] [Abstract][Full Text] [Related]
13. Apoptotic study in Graves disease treated with thyroid arterial embolization. Zhao W; Gao BL; Yi GF; Jin CZ; Yang HY; Shen LJ; Tian M; Yu YZ; Li H; Song DP Endocr J; 2009; 56(2):201-11. PubMed ID: 19008632 [TBL] [Abstract][Full Text] [Related]
14. A long-term follow-up study of patients with non-toxic diffuse goitre in Japan. Hara T; Tamai H; Mukuta T; Fukata S; Kuma K; Nakagawa T Clin Endocrinol (Oxf); 1993 Nov; 39(5):541-6. PubMed ID: 8252742 [TBL] [Abstract][Full Text] [Related]
15. Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy. Nygaard B; Faber J; Veje A; Hegedüs L; Hansen JM Thyroid; 1999 May; 9(5):477-81. PubMed ID: 10365679 [TBL] [Abstract][Full Text] [Related]
16. Roles of Thyroid Hormones, Mast Cells, and Inflammatory Mediators in the Initiation and Progression of Autoimmune Thyroid Diseases. Zdor VV; Geltser BI; Eliseikina MG; Markelova EV; Tikhonov YN; Plekhova NG; Karaulov AV Int Arch Allergy Immunol; 2020; 181(9):715-726. PubMed ID: 32640447 [TBL] [Abstract][Full Text] [Related]
17. Increased serum CXCL10 in Graves' disease or autoimmune thyroiditis is not associated with hyper- or hypothyroidism per se, but is specifically sustained by the autoimmune, inflammatory process. Antonelli A; Fallahi P; Rotondi M; Ferrari SM; Romagnani P; Grosso M; Ferrannini E; Serio M Eur J Endocrinol; 2006 May; 154(5):651-8. PubMed ID: 16645011 [TBL] [Abstract][Full Text] [Related]
18. IGF1 deficiency in newly diagnosed Graves' disease patients. Martin S; Sirbu A; Betivoiu M; Florea S; Barbu C; Fica S Hormones (Athens); 2015; 14(4):651-9. PubMed ID: 26188228 [TBL] [Abstract][Full Text] [Related]
19. Thyroid autoimmunity and thyroid autonomy. Vitti P; Mariotti S; Marcocci C; Chiovato L; Giachetti M; Fenzi G; Pinchera A Acta Med Austriaca; 1990; 17 Suppl 1():90-2. PubMed ID: 2202187 [TBL] [Abstract][Full Text] [Related]
20. [Clinical aspects of hyperthyroidism in areas of different supplies of iodine. Results of a European prospective study]. Reinwein D; Benker G; König MP; Pinchera A; Schatz H; Schleusener H Schweiz Med Wochenschr; 1987 Aug; 117(34):1245-55. PubMed ID: 3672070 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]